摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

R-1-(2-furyl)-2-chloroethanol-N-methylcarbamate | 769140-92-3

中文名称
——
中文别名
——
英文名称
R-1-(2-furyl)-2-chloroethanol-N-methylcarbamate
英文别名
[(1R)-2-chloro-1-(furan-2-yl)ethyl] N-methylcarbamate
R-1-(2-furyl)-2-chloroethanol-N-methylcarbamate化学式
CAS
769140-92-3
化学式
C8H10ClNO3
mdl
——
分子量
203.625
InChiKey
UYCIQVBDBJJAQU-ZETCQYMHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    13
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    51.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Solvent and in situ catalyst preparation impacts upon Noyori reductions of aryl-chloromethyl ketones: application to syntheses of chiral 2-amino-1-aryl-ethanols
    摘要:
    As part of medicinal chemistry efforts we found it necessary to develop general syntheses of highly enantiomerically enriched 1-aryl-2-chloroethanols and 1-aryl-2-methylaminoethanols. A survey of literature methods suggested that a truly general approach had not yet been reported, encouraging us to undertake the development of such a methodology. This study describes the design, development, and reduction to practice of a general synthesis of chiral 1-aryl-2-chloroethanols and the transformation of these entities to highly enantiomerically enriched 1-aryl-2-methylaminoethanols. Of particular importance were observations of the impact of solvent and the method of catalyst preparation on the yield and enantiomerical excess of chlorohydrins prepared via Noyori transfer hydrogenations of aryl-chloromethyl ketones. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2006.07.017
  • 作为产物:
    描述:
    2-乙酰基呋喃 在 [ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]2(1S,2S)-(+)-N-对甲苯磺酰基-1,2-二苯基乙二胺 N-氯代丁二酰亚胺甲酸氢氟酸三乙胺N,N-二异丙基乙胺 作用下, 以 四氢呋喃二氯甲烷N,N-二甲基甲酰胺乙腈 为溶剂, 反应 4.5h, 生成 R-1-(2-furyl)-2-chloroethanol-N-methylcarbamate
    参考文献:
    名称:
    Solvent and in situ catalyst preparation impacts upon Noyori reductions of aryl-chloromethyl ketones: application to syntheses of chiral 2-amino-1-aryl-ethanols
    摘要:
    As part of medicinal chemistry efforts we found it necessary to develop general syntheses of highly enantiomerically enriched 1-aryl-2-chloroethanols and 1-aryl-2-methylaminoethanols. A survey of literature methods suggested that a truly general approach had not yet been reported, encouraging us to undertake the development of such a methodology. This study describes the design, development, and reduction to practice of a general synthesis of chiral 1-aryl-2-chloroethanols and the transformation of these entities to highly enantiomerically enriched 1-aryl-2-methylaminoethanols. Of particular importance were observations of the impact of solvent and the method of catalyst preparation on the yield and enantiomerical excess of chlorohydrins prepared via Noyori transfer hydrogenations of aryl-chloromethyl ketones. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2006.07.017
点击查看最新优质反应信息

文献信息

  • [EN] PROCESS TO PRODUCE ENANTIOMERICALLY ENRICHED 1-ARYL- AND 1-HETEROARYL-2-AMINOETHANOLS<br/>[FR] PROCEDE DE PREPARATION D'1-ARYL- ET D'1-HETEROARYL-2-AMINOETHANOLS ENRICHIS EN ENANTIOMERES
    申请人:UPJOHN CO
    公开号:WO2004085414A1
    公开(公告)日:2004-10-07
    The invention relates to a method of preparing enantiomerically enriched amino alcohols of Formula (I) wherein the variable R1, R2, and R3 are defined herein.
    这项发明涉及一种制备式(I)的对映体富集氨基醇的方法,其中变量R1、R2和R3在此处被定义。
  • Process to produce enantiomerically enriched 1-aryl-and 1-heteroaryl-2-aminoethanols
    申请人:Pfizer, Inc.
    公开号:US20040236151A1
    公开(公告)日:2004-11-25
    The invention relates to a method of preparing enantiomerically enriched amino alcohols of Formula I 1 wherein the variable R1, R2, and R3 are defined herein.
    本发明涉及一种制备对映体富集的式I1的氨基醇的方法,其中变量R1、R2和R3在此处定义。
  • EP1611113A1
    申请人:——
    公开号:EP1611113A1
    公开(公告)日:2006-01-04
  • Solvent and in situ catalyst preparation impacts upon Noyori reductions of aryl-chloromethyl ketones: application to syntheses of chiral 2-amino-1-aryl-ethanols
    作者:Steven P. Tanis、Bruce R. Evans、James A. Nieman、Timothy T. Parker、Wendy D. Taylor、Steven E. Heasley、Paul M. Herrinton、William R. Perrault、Richard A. Hohler、Lester A. Dolak、Matthew R. Hester、Eric P. Seest
    DOI:10.1016/j.tetasy.2006.07.017
    日期:2006.8
    As part of medicinal chemistry efforts we found it necessary to develop general syntheses of highly enantiomerically enriched 1-aryl-2-chloroethanols and 1-aryl-2-methylaminoethanols. A survey of literature methods suggested that a truly general approach had not yet been reported, encouraging us to undertake the development of such a methodology. This study describes the design, development, and reduction to practice of a general synthesis of chiral 1-aryl-2-chloroethanols and the transformation of these entities to highly enantiomerically enriched 1-aryl-2-methylaminoethanols. Of particular importance were observations of the impact of solvent and the method of catalyst preparation on the yield and enantiomerical excess of chlorohydrins prepared via Noyori transfer hydrogenations of aryl-chloromethyl ketones. (c) 2006 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

香薷二醇 顺式-1-(2-呋喃基)-1-戊烯 顺-1,2-二氰基-1,2-双(2,4,5-三甲基-3-噻吩基)乙烯 顺-1,2-(2-噻嗯基)二乙烯 雷尼替丁-N,S-二氧化物 雷尼替丁-N-氧化物 西拉诺德 螺[环氧乙烷-2,3'-吡咯并[1,2-a]吡嗪] 萘并[2,1,8-def]喹啉 苯硫基溴化镁 苯甲酸,2-[[[7-[[(3.β.)-3-羟基-28-羰基羽扇-20(29)-烯-28-基]amino]庚基]氨基]羰基] 苍术素 缩水甘油糠醚 紫苏烯 糠醛肟 糠醇-d2 糠醇 糠基硫醇-d2 糠基硫醇 糠基甲基硫醚 糠基氯 糠基氨基甲酸异丙酯 糠基丙基醚 糠基丙基二硫醚 糠基3-巯基-2-甲基丙酸酯 糠基-异戊基醚 糠基-异丁基醚 糠基 2-甲基-3-呋喃基二硫醚 磷杂茂 硫酸异丙基糠酯 硫代磷酸O-糠基O-甲基S-(2-丙炔基)酯 硫代磷酸O-乙基O-糠基S-(2-丙炔基)酯 硫代甲酸S-糠酯 硫代噻吩甲酰基三氟丙酮 硫代乙酸糠酯 硫代丙酸糠酯 硅烷,三(1-甲基乙基)[(3-甲基-2-呋喃基)氧代]- 硅烷,(1,1-二甲基乙基)(2-呋喃基甲氧基)二甲基- 砷杂苯 甲酸糠酯 甲氧亚胺基呋喃乙酸铵盐 甲基糠基醚 甲基糠基二硫 甲基呋喃-2-基甲基氨基甲酸酯 甲基丙烯酸糠酯 甲基5-(羟基甲基)-2-呋喃甲亚氨酸酯 甲基(2Z)-3-甲基-2-(甲基亚胺)-4-氧代-3,4-二氢-2H-1,3-噻嗪-6-羧酸酯 甲基(2Z)-3-氨基-2-(甲基亚胺)-4-氧代-3,4-二氢-2H-1,3-噻嗪-6-羧酸酯 甲基(2Z)-3-异丙基-2-(异丙基亚胺)-4-氧代-3,4-二氢-2H-1,3-噻嗪-6-羧酸酯 甲基(2-甲基-3-呋喃基)二硫